Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech
Lori S. Friedman, Ph.D., director, Cancer Signaling and Translational Oncology, Genentech gives a presentation at the 2009 AACR meeting in Denver on: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer.